Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

GM Titamax Implant,Ti,4.0X7: medical device reports filed with FDA

325 reports name it, 2020–2026. Manufacturer given most often on reports: Jjgc. Product code DZE.

325
device reports naming the brand
0% of all MAUDE reports · about 53 a year
134
reports, 12 months to August 2026
73 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 325 reports that name the brand "GM Titamax Implant,Ti,4.0X7" (endosseous dental implant), received between May 2020 and August 2026; the manufacturer given most often on reports is Jjgc. Spellings of one product vary from report to report.

134 reports arrived in the 12 months to August 2026, up 84% from 73 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (76.6%), loss of osseointegration (11.4%) and difficult to insert (1.8%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0816Sep 2021: 0Oct 2021: 2Nov 2021: 1Dec 2021: 32022Jan 2022: 1Feb 2022: 2Mar 2022: 0Apr 2022: 1May 2022: 1Jun 2022: 0Jul 2022: 2Aug 2022: 4Sep 2022: 1Oct 2022: 5Nov 2022: 2Dec 2022: 12023Jan 2023: 4Feb 2023: 1Mar 2023: 1Apr 2023: 0May 2023: 4Jun 2023: 4Jul 2023: 4Aug 2023: 7Sep 2023: 10Oct 2023: 8Nov 2023: 4Dec 2023: 32024Jan 2024: 2Feb 2024: 0Mar 2024: 6Apr 2024: 7May 2024: 4Jun 2024: 3Jul 2024: 5Aug 2024: 2Sep 2024: 10Oct 2024: 4Nov 2024: 3Dec 2024: 42025Jan 2025: 6Feb 2025: 11Mar 2025: 1Apr 2025: 2May 2025: 0Jun 2025: 9Jul 2025: 16Aug 2025: 7Sep 2025: 14Oct 2025: 16Nov 2025: 7Dec 2025: 122026Jan 2026: 8Feb 2026: 12Mar 2026: 15Apr 2026: 8May 2026: 14Jun 2026: 5Jul 2026: 16Aug 2026: 7

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0511012020: 820202021: 1120212022: 2020222023: 5020232024: 5020242025: 10120252026: 852026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%325
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report95.7%311
Voluntary report0%0
User facility report0%0
Distributor report4.3%14
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate24976.6%62.8%
Loss of osseointegration3711.4%22.4%
Difficult to insertthe device was hard to insert61.8%0.4%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis9529.2%
Painpain, site not specified7924.3%
Inflammationinflammation288.6%
Swelling/ edema206.2%
Fistula113.4%
Abscessa collection of pus92.8%
Hyperresponsive to stimuli61.8%
Hemorrhage/blood loss/bleeding51.5%
Sinus perforation20.6%
Numbnessnumbness10.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureGM Titamax Implant,Ti,4.0X7Product code DZEAll MAUDE reports
Reports3253,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer95.7%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about GM Titamax Implant,Ti,4.0X7 reports

How many FDA reports name GM Titamax Implant,Ti,4.0X7?

325 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 134 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (76.6%), loss of osseointegration (11.4%) and difficult to insert (1.8%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (95.7%) and distributor reports (4.3%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that GM Titamax Implant,Ti,4.0X7 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.